Loading...
•
Dec 31, 2020
Amedisys Q4 2020 Earnings Report
Amedisys reported strong Q4 2020 financial results, with revenue and net income increasing compared to the same period in 2019.
Key Takeaways
Amedisys reported a revenue of $550.7 million and a net income of $45.2 million for Q4 2020. The company's adjusted EPS was $1.49, and they have issued 2021 guidance with revenue expected to be in the range of $2.275 billion to $2.315 billion.
Net service revenue increased to $550.7 million from $500.7 million in Q4 2019.
Net income attributable to Amedisys, Inc. was $45.2 million, compared to $27.7 million in Q4 2019.
Adjusted net income attributable to Amedisys, Inc. per diluted share was $1.49, up from $0.94 in Q4 2019.
The company issued 2021 guidance, projecting net service revenue between $2.275 billion and $2.315 billion.
Amedisys
Amedisys
Forward Guidance
Amedisys anticipates net service revenue to be in the range of $2.275 billion to $2.315 billion, adjusted EBITDA to be in the range of $315 million to $325 million, and adjusted diluted earnings per share to be in the range of $6.25 to $6.47 for 2021.
Positive Outlook
- Net service revenue is anticipated to be in the range of $2.275 billion to $2.315 billion.
- Adjusted EBITDA is anticipated to be in the range of $315 million to $325 million.
- Adjusted diluted earnings per share is anticipated to be in the range of $6.25 to $6.47.
- Guidance excludes the effects of any future acquisitions.
- Guidance excludes potential share repurchases.
Challenges Ahead
- Home health, hospice and personal care industries are highly competitive.
- Industries are subject to intensive regulations.
- Trends are subject to numerous factors, risks, and uncertainties.
- Trends are subject to changes in Medicare and other medical payment levels.
- Trends are subject to future cost containment initiatives undertaken by third-party payors.